[1]
Soliman, A.T. et al. 2018. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC. Acta Biomedica Atenei Parmensis. 89, 2-S (Feb. 2018), 27–32. DOI:https://doi.org/10.23750/abm.v89i2-S.7084.